News Website

Dostarlimab/Chemo Shows OS Benefit Regardless of MMR Status in Endometrial Cancer - OncLive

Dostarlimab/Chemo Shows OS Benefit Regardless of MMR Status in Endometrial Cancer OncLive

Published: July 3, 2024, 7 a.m.

Read Full Article

Durvalumab Plus Olaparib Approaches EU Approval for pMMR Advanced or Recurrent Endometrial Cancer - OncLive

Durvalumab Plus Olaparib Approaches EU Approval for pMMR Advanced or Recurrent Endometrial Cancer OncLive

Published: July 1, 2024, 7 a.m.

Read Full Article

Genetic alteration of mRNA editing enzyme APOBEC3B in the pathogenesis of ovarian endometriosis.

What are the specific genetic alterations and associated network in endometriotic cells responsible for the disease pathogenesis?

Published: May 23, 2024, midnight

Read Full Article

A1CF APOBEC3B deletion Endometriomas Endometriosis Pathogenesis Whole exome sequencing

Dr Bou Farhat on a Retrospective Study of NGS vs IHC Sensitivity for dMMR CRC and Endometrial Cancer - OncLive

Dr Bou Farhat on a Retrospective Study of NGS vs IHC Sensitivity for dMMR CRC and Endometrial Cancer OncLive

Published: May 21, 2024, 7 a.m.

Read Full Article

Dr Porter on Mirvetuximab Soravtansine Plus Pembrolizumab in FRα+ pMMR/MSS Endometrial Cancer - OncLive

Dr Porter on Mirvetuximab Soravtansine Plus Pembrolizumab in FRα+ pMMR/MSS Endometrial Cancer OncLive

Published: April 8, 2024, 7 a.m.

Read Full Article

Differentiating Between dMMR and pMMR Subtypes of Endometrial Cancer - OncLive

Differentiating Between dMMR and pMMR Subtypes of Endometrial Cancer OncLive

Published: April 2, 2024, 7 a.m.

Read Full Article

Magnetic Resonance-Guided Focused Ultrasound Surgery for Gynecologic Indications.

Magnetic resonance-guided focused ultrasound surgery (MRgFUS) appears to be an effective and safe treatment for uterine fibroids and adenomyosis, particularly in women who wish to preserve fertility. In abdominal wall …

Published: March 27, 2024, midnight

Read Full Article

Focused ultrasound surgery Gynecologic indications MRI MRgFUS

Philips to spotlight helium-free MRI options at ECR 2024 - AuntMinnie Europe

Philips to spotlight helium-free MRI options at ECR 2024 AuntMinnie Europe

Published: Feb. 9, 2024, 8 a.m.

Read Full Article

MRI helps clinicians assess neural involvement in endometriosis - AuntMinnie

MRI helps clinicians assess neural involvement in endometriosis AuntMinnie

Published: Jan. 4, 2024, 8 a.m.

Read Full Article

Causal effects of genetically predicted endometriosis on breast cancer: a two-sample Mendelian randomization study.

This study used a Mendelian randomization (MR) approach to investigate the causal relationship between genetically predicted endometriosis (EMS) and breast cancer risk. A total of 122,977 cases and 105,974 controls …

Published: Oct. 12, 2023, midnight

Read Full Article

Latest Articles

Dostarlimab/Chemo Shows OS Benefit Regardless of MMR Status in Endometrial Cancer - OncLive

Durvalumab Plus Olaparib Approaches EU Approval for pMMR Advanced or Recurrent Endometrial Cancer - OncLive

Genetic alteration of mRNA editing enzyme APOBEC3B in the pathogenesis of ovarian endometriosis.

Dr Bou Farhat on a Retrospective Study of NGS vs IHC Sensitivity for dMMR CRC and Endometrial Cancer - OncLive

Dr Porter on Mirvetuximab Soravtansine Plus Pembrolizumab in FRα+ pMMR/MSS Endometrial Cancer - OncLive

Differentiating Between dMMR and pMMR Subtypes of Endometrial Cancer - OncLive

Magnetic Resonance-Guided Focused Ultrasound Surgery for Gynecologic Indications.

Philips to spotlight helium-free MRI options at ECR 2024 - AuntMinnie Europe

MRI helps clinicians assess neural involvement in endometriosis - AuntMinnie

Causal effects of genetically predicted endometriosis on breast cancer: a two-sample Mendelian randomization study.

Subscribe to Our Newsletter